Pharmacokinetics of Alisertib in Adults With Advanced Solid Tumors or Relapsed/Refractory Lymphoma With Varying Degrees of Hepatic Function
Clinical trial NCT02214147 · COMPLETED
Trial details
- NCT number
- NCT02214147
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-21
- Primary completion
- 2016-04-05
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.